PIŚMIENNICTWO
1. Dale H.H.: On some physiological actions of ergot. J. Physiol. 1906, 34, 163-206. – 2. Love T.M.: Oxytocin, motivation and the role of dopamine. Pharmacol. Biochem. Behav. 2013, http://dx.doi.org/10.1016/j.pbb.2013.06.011. – 3. Onaka T.: Neural pathways controlling central and peripheral oxytocin release during stress. J. Neuroendocrinol. 16, 308-12, 2004. – 4. Moos F., Freund-Mercier M.J., Guerne Y., Guerne J.M., Stoeckel M.F., Richard P.: Release of oxytocin and vasopressin by magnocellular nuclei in vitro: specific facilatory effect of oxytocin on its own release. J. Endocrinol. 1984, 102, 63-72. – 5. Stoop R.: Neuromodulation by oxytocin and vasopressin. Neuron 76, 142-59, 2012. – 6. Bartz J.A., Zaki J., Bolger N., Ochsner K.N.: Social effects of oxytocin in humans: context and person matter. Trends Cogn. Sci. 15, 301-9, 2011. – 7. Cardoso C., Ellnbogen M.A., Orlando M.A., Bacon S.L., Joober R.: Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study. Psychoneuroendocrinol. 38, 399-407, 2013. – 8. Love T.M., Enoch M.A., Hodkinson C.A., Pecina M., Mickey B., Koeppe R.A., Stohler C.S., Goldman D., Zubieta J.K.: Oxytocin gene polymorphism influence human dopaminergic function in a sex-dependent manner. Biol. Psychiatry 72, 198-206, 2012. – 9. Lee H.J., Macbeth A.H., Pagani J.H., Young W.S.: Oxytocin: the great facilitator of life. Progr. Neurobiol. 88, 127-51, 2009. – 10. Sarnyai Z.: Oxytoocin as a potential mediator and modulator of drug addiction. Addict. Biol. 16, 199-201, 2011.
11. Pfister H.P., Muir J.L.: Influence of exogenously administered oxytocin on central noradrenaline, dopamine and serotonin levels following psychological stress in nulliparous female rats (Rattus norvegicus). Int. J. Neurosci. 45, 221-9, 1989. – 12. Becker J.B.: Sexual differentiation of motivation: A novel mechanism? Horm. Behav. 55, 646-54, 2009. – 13. Wrońska-Fortuna D., Sechman A., Hrabia A., Zięba D.: Effect of hypothalamic neuropeptides (CRH, AVP and OXY) on in vitro cortisol release by sheep adrenal gland. 18th International Symposium of the Polish Network of Molecular and Cellular Biology, 17-18 September 2009. Materials, 372-3. – 14. Parker K.J., Buckmaster C.L., Schatzberg A.F., Lyons D.M.: Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinol. 30, 924-9, 2005. – 15. Parker K.J., Kenna H.A., Zeitzer J.M., Keller J., Blasey C.M., Amico J.A., Schatzberg A.F.: Preliminary evidence that plasma oxytocin levels reelevated in major depression. Psych. Res. 178, 359-62, 2010. – 16. Lim M.M., Young L.J.: Neuropeptidergic regulation of affiliative behavior and social bonding in animals. Horm. Behav. 50, 506-17, 2006. – 17. Landgraf R., Neumann I.D.: Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 25, 150-76, 2004. – 18. Amico J.A., Mantella R.C., Vollmer R.R., Li X.: Anxiety and stress responses in female oxytocin deficient mice. J. Neuroendocrinol. 16, 319-24, 2004. – 19. Parker K.J., Schatzberg A.F., Lyons D.M.: Neuroendocrine aspects of hypercortisolism in major depression. Horm. Behav. 42, 60-6, 2003. – 20. Swedo S.E., Leonard H.I., Kruesi M.J., Rettew D.C., Listwak S.J., Berrettini W., Stipetic M., Hamburger S., Gold P.W., Potter W.Z., Rapoport J.L.: Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Arch. Gen. Psychiatry 49, 29-36, 1992. - 21. Scantamburlo G., Hansenne M., Fuchs S., Pitchot W., Marechal P., Pequeux C., Ansseau M., Legros J.L.: Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinol. 32, 407-10, 2007. – 22. Cyranowski J.M., Hofkens T.L., Frank E., Seltman H., Cai H.M., Amico J.A.: Evidence of dysregulated peripheral oxytocin release among depressed women. Psychosomatic Med. 70, 967-75, 2008. – 23. Veening J.G., Olivier B.: Intranasal administration of oxytocin: Behavioral and clinical effects, a review. Neurosci. Biobehav. Rev. 37, 1445-1465, 2013. – 24. Bethlehem R.A.I., van Honk J., Auyeung B., Baron-Cohen S.: Oxytocin, brain physiology, and functional connectivity: A review of intranasal oxytocin fMRI studies. Psychoneuroendocrinology 38, 962-974, 2013. 25. Garson D.S., Berquist S.W., Trujillo T.H., Garner J.P., Hannah S.L., Hyde S.A., Sumiyoshi P.D., Jackson L.P., Moss J.K., Strehlow M.C., Cheshier S.H., Partap S., Hardan A.Y., Parker K.J.: Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict ankiety in children. Molecular Psychiatry 2014, 1-6, 4 November 2014; doi:10.1038/mp.2014.132
